Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Abbott Laboratories ABT
$109.64
-$0.41 (-0.37%)
На 18:00, 12 мая 2023
+18.95%
Потенциал через год
Ранг: 2
Ключевые показатели
-
Marketcap
190593443024.00000000
-
week52high
118.23
-
week52low
93.25
-
Revenue
43653000000
-
P/E TTM
33
-
Beta
0.66055300
-
EPS
3.29000000
-
Last Dividend
2.04000000
-
Next Earnings Date
18 июл 2023 г. в 12:30
Описание компании
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Рекомендации
аналитиков
Рекомендации аналитиков
Grading company | New grade | Previous grade | Recommendation date |
---|---|---|---|
UBS | Buy | Buy | 27 июл 2022 г. |
RBC Capital | Outperform | Outperform | 21 июл 2022 г. |
Morgan Stanley | Overweight | Overweight | 21 июл 2022 г. |
Citigroup | Buy | Buy | 21 июл 2022 г. |
Stifel | Buy | Buy | 18 июл 2022 г. |
Jefferies | Hold | 12 окт 2022 г. | |
Morgan Stanley | Overweight | Overweight | 11 окт 2022 г. |
Wells Fargo | Overweight | Overweight | 10 окт 2022 г. |
Raymond James | Outperform | Outperform | 21 окт 2022 г. |
Barclays | Overweight | Overweight | 21 окт 2022 г. |
RBC Capital | Outperform | Outperform | 20 окт 2022 г. |
Morgan Stanley | Overweight | Overweight | 20 окт 2022 г. |
Barclays | Overweight | 18 окт 2022 г. | |
Mizuho | Neutral | 26 окт 2022 г. | |
Citigroup | Buy | Buy | 12 дек 2022 г. |
Morgan Stanley | Overweight | Overweight | 06 янв 2023 г. |
Barclays | Overweight | Overweight | 27 янв 2023 г. |
Stifel | Buy | Buy | 26 янв 2023 г. |
Raymond James | Outperform | Outperform | 26 янв 2023 г. |
Bernstein | Outperform | Outperform | 26 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Покожие компании
Новостная лента
компании
Insider Summary
Insider Summary
Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
---|---|---|---|---|
Gonzalez Patricia Paola | A | 1561 | 300 | 31 дек 2022 г. |
Roman Michael F | A | 1949 | 300 | 31 дек 2022 г. |
Stratton John G | A | 8571 | 300 | 31 дек 2022 г. |
Alpern Robert J | A | 9030 | 71 | 31 дек 2022 г. |
Karam Sammy | D | 26462 | 4200 | 29 дек 2022 г. |
Ginascol John F | D | 111912 | 11000 | 13 дек 2022 г. |
STARKS DANIEL J | D | 6873500 | 9313 | 27 окт 2022 г. |
STARKS DANIEL J | D | 6882813 | 40687 | 27 окт 2022 г. |
Ahlberg Gregory A | D | 33053 | 221 | 01 окт 2022 г. |
Stratton John G | A | 8233 | 341 | 30 сент 2022 г. |
Institutional Ownership
Institutional Ownership
Holder | Shares | Change | Date Reported |
---|---|---|---|
Vanguard Total Stock Market Index Fund | 49834300 | -437805 | 31 авг 2020 г. |
Vanguard 500 Index Fund | 36345200 | -133073 | 31 авг 2020 г. |
SPDR S&P 500 ETF | 18656000 | -88478 | 31 авг 2020 г. |
US Bank Vanguard Institutional 500 Index Trust | 15197100 | -70126 | 31 авг 2020 г. |
Fidelity 500 Index Fund | 15755900 | -17051 | 31 июл 2020 г. |
American Funds Investment Company of America | 30723900 | -420284 | 30 июн 2020 г. |
American Funds Growth Fund of America | 24057800 | -4365790 | 30 июн 2020 г. |
American Funds AMCAP Fund | 22373200 | -1225010 | 30 июн 2020 г. |
Vanguard Health Care Fund | 14946300 | 0 | 30 июн 2020 г. |
American Funds Capital World Growth & Income Fund | 13609000 | -8400 | 30 июн 2020 г. |
Новостная лента
Abbott (ABT) EPD Business Grows Strong, Macro Issues Stay
Zacks Investment Research
08 мая 2023 г. в 12:11
Abbott (ABT) continues to make good progress, increasing manufacturing production and recovering market share in the Nutrition business.
3 Dividend Stock Warning Signs That Could Portend Trouble
The Motley Fool
06 мая 2023 г. в 05:30
Sharply rising payout ratios and negative payout ratios are both big red flags. The slowing or pausing of annual dividend growth is a major warning sign.
Only 2 Companies Are AAA Rated As U.S. Risks Being A Deadbeat
Investors Business Daily
03 мая 2023 г. в 08:00
Lawmakers are playing chicken with the debt ceiling. Luckily there are still two U.S. S&P 500 companies left with AAA credit ratings.
3 Dividend Aristocrats To Help Beat Stagflation
Seeking Alpha
02 мая 2023 г. в 08:05
High Inflation combined with low economic growth creates a period of stagflation, but these stocks can still outperform. All 3 of these dividend stocks have paid a growing dividend for 25+ CONSECUTIVE years.
3 Stocks to Buy Before They Soar to New Heights in 2023
InvestorPlace
01 мая 2023 г. в 11:29
Many stocks are recovering from the losses they endured last year, with some looking ready to break out and test new highs. Many of the top stocks to buy in down markets have led the way higher in 2023.